《Nature,5月22日,Machine Learning for COVID-19 needs global collaboration and data-sharing》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-05-23
  • Machine Learning for COVID-19 needs global collaboration and data-sharing

    Nathan Peiffer-Smadja, Redwan Maatoug, François-Xavier Lescure, Eric D’Ortenzio, Joëlle Pineau & Jean-Rémi King

    Nature Machine Intelligence (2020)

    The COVID-19 pandemic poses a historical challenge to society. The profusion of data requires machine learning to improve and accelerate COVID-19 diagnosis, prognosis and treatment. However, a global and open approach is necessary to avoid pitfalls in these applications.

    On 31 December 2019, the first cases of a viral pneumonia with unknown aetiology were reported in the city of Wuhan, China. In the following weeks, the Chinese authorities and the World Health Organization (WHO) announced the discovery of a novel coronavirus and its associated disease: SARS-CoV-2 and COVID-19, respectively. On 21 April 2020, the number of cases of COVID-19 exceeded 2.4 million and the death toll exceeded 170,000 worldwide1. The outbreak of COVID-19 represents a major and urgent threat to global health. While the unprecedented speed of the COVID-19 spread partly finds its roots in our increasingly globalized society, the global sharing of scientific data also offers a promising tool to fight the disease. In the past four months, more than 12,400 articles have been published2 and scientific data collected from thousands of patients have been released3. The majority of these studies follow the standard scientific method: that is, investigate a few hypotheses at a time on a controlled sample. While undeniably successful, this standard method suffers from two well-known challenges, both critical to our pandemic situation: (1) it requires considerable expertise and human input and (2) it only considers a handful hypotheses at a time. Machine learning (ML) has been used to meet these challenges in various pathologies4,5, including infectious diseases6. Herein, we describe two areas where ML could supplement standard statistical methods in the COVID-19 pandemic, discuss the practical challenges that such a ML approach entails, and advocate for a global collaboration and data-sharing.

  • 原文来源:https://www.nature.com/articles/s42256-020-0181-6
相关报告
  • 《Nature,5月5日,COVID-19 pandemic: the effects of quarantine on cardiovascular risk》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-05-06
    • COVID-19 pandemic: the effects of quarantine on cardiovascular risk Anna Vittoria Mattioli, Matteo Ballerini Puviani, Milena Nasi & Alberto Farinetti European Journal of Clinical Nutrition (2020) Abstract COVID-19 is causing a global pandemic with a high number of deaths and infected people. To contain the diffusion of COVID-19 virus, Governments have enforced restrictions on outdoor activities or even collective quarantine on the population. One important consequence of quarantine is a change in lifestyle: reduced physical activity and unhealthy diet. 2019 guidelines for primary prevention of cardiovascular disease indicate that “Adults should engage in at least 150 minute per week of accumulated moderate-intensity or 75 minute per week of vigorous-intensity aerobic physical activity (or an equivalent combination of moderate and vigorous activity) to reduce ASCVD risk.” During quarantine, strategies to further increase home-based physical activity and to follow a healthy diet should be implemented. Quarantine carries some long-term effects on cardiovascular disease, mainly related to unhealthy lifestyle and anxiety. Following quarantine a global action supporting healthy diet and physical activity is mandatory to encourage people to return to good lifestyle.
  • 《LANCET,5月15日,Tracheostomy in the COVID-19 era: global and multidisciplinary guidance》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-05-16
    • Tracheostomy in the COVID-19 era: global and multidisciplinary guidance Brendan A McGrath, PhD † Michael J Brenner, MD † Stephen J Warrillow, PhD Vinciya Pandian, PhD Asit Arora, PhD Tanis S Cameron, MA et al. Show all authors Show footnotes Published:May 15, 2020DOI:https://doi.org/10.1016/S2213-2600(20)30230-7 Global health care is experiencing an unprecedented surge in the number of critically ill patients who require mechanical ventilation due to the COVID-19 pandemic. The requirement for relatively long periods of ventilation in those who survive means that many are considered for tracheostomy to free patients from ventilatory support and maximise scarce resources. COVID-19 provides unique challenges for tracheostomy care: health-care workers need to safely undertake tracheostomy procedures and manage patients afterwards, minimising risks of nosocomial transmission and compromises in the quality of care. Conflicting recommendations exist about case selection, the timing and performance of tracheostomy, and the subsequent management of patients. In response, we convened an international working group of individuals with relevant expertise in tracheostomy. We did a literature and internet search for reports of research pertaining to tracheostomy during the COVID-19 pandemic, supplemented by sources comprising statements and guidance on tracheostomy care. By synthesising early experiences from countries that have managed a surge in patient numbers, emerging virological data, and international, multidisciplinary expert opinion, we aim to provide consensus guidelines and recommendations on the conduct and management of tracheostomy during the COVID-19 pandemic.